Politics John Wilkerson STAT Plus: NIH-funded clinical trials often miss racial, gender diversity enrollment goals, report finds
In the Lab Adam Piore — Boston Globe STAT Plus: Harvard scientists unveil the most detailed map of the brain ever: ‘It’s an alien world inside your own head’
In the Lab Theresa Gaffney STAT Plus: NIH postdocs will get a raise next year — but not as much as they hoped
Politics Jonathan Wosen STAT Plus: NCI director expresses optimism about next era of cancer research, despite shrinking budget and brain drain
Health Isabella Cueto STAT Plus: Inside a push to create an NIH office for post-infection chronic illness
First Opinion Elizabeth Weaver II and Kiana Jackson Disabled scientists are often left out of academia. The NIH can help change that
In the Lab Isabella Cueto NIH study of ME/CFS points to immune dysfunction and brain abnormalities at core of long-dismissed disease
In the Lab Megan Molteni ‘All of Us’ reports half of the genomes it has sequenced are from non-Europeans
Politics Sarah Owermohle STAT Plus: The new NIH director is walking a tightrope on Biden’s drug pricing vision
First Opinion Lynne Moronski How to ensure the NIH’s decision to recognize people with disabilities as a health disparity population makes a difference
Special Report Sarah Owermohle HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy
Pharmalot Ed Silverman STAT Plus: In response to criticism, FDA publishes new database of wayward clinical trial sponsors
Politics Sarah Owermohle STAT Plus: Biden appoints Vanderbilt oncologist to head National Cancer Institute
Politics Rachel Cohrs Zhang STAT Plus: New NIH head says government has fallen behind pharma on clinical trials
Health tech Katie Palmer STAT Plus: With a new center, All of Us tackles health data silos to power precision medicine
Politics Sarah Owermohle STAT Plus: NIH confirmation hearing highlights just how divisive the agency’s portfolio has become
Politics Sarah Owermohle and Angus Chen STAT Plus: What to make of Biden’s latest Cancer Moonshot efforts
Politics John Wilkerson STAT Plus: NIH nominee Bertagnolli will get a confirmation hearing next month, Sanders says
First Opinion Mark J. Ratain The best way for the NIH to reduce drug prices is to address drug spending